Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    19965662 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed
Has Results 		Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma
Condition: Lymphoma
Intervention: Drug: fostamatinib
To Top

† Indicates status has not been verified in more than two years